
Opinion|Videos|October 14, 2024
Navigating PD-1/PD-L1 Agents: Influential Factors in Choosing the Right Therapy
Key Takeaways
- Route of administration impacts patient compliance and convenience, influencing the choice of PD-1/PD-L1 agents.
- Duration of therapy affects patients' quality of life and is a key consideration in treatment selection.
Panelists discuss how various factors, such as route of administration, duration of therapy, safety, efficacy, and cost, could influence the selection of different PD-1/PD-L1 agents once they receive approval, highlighting the importance of these considerations in optimizing patient care.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What factors could influence the choice between different PD-1/PD-L1 agents if they are eventually approved [ie, route of administration, duration of therapy, safety, efficacy, place of administration, drug preservation, biomarkers, cost, etc]?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
AI-generated profiles impersonate female urologists to market ED products online
2
John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC
3
App-based intervention aims to increase PSA screening among Black men
4
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD
5


